These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32621327)

  • 41. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study.
    Johannsson G; Lennernäs H; Marelli C; Rockich K; Skrtic S
    Eur J Endocrinol; 2016 Jul; 175(1):85-93. PubMed ID: 27129362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of the therapy shift from cortisone acetate to modified-release hydrocortisone in a group of patients with adrenal insufficiency.
    Frigerio S; Carosi G; Ferrante E; Sala E; Polledri E; Fustinoni S; Ambrosi B; Chiodini I; Mantovani G; Morelli V; Arosio M
    Front Endocrinol (Lausanne); 2023; 14():1093838. PubMed ID: 36761196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy.
    Johannsson G; Falorni A; Skrtic S; Lennernäs H; Quinkler M; Monson JP; Stewart PM
    Clin Endocrinol (Oxf); 2015 Jan; 82(1):2-11. PubMed ID: 25187037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review.
    Rahvar AH; Haas CS; Danneberg S; Harbeck B
    Biomed Res Int; 2017; 2017():3691913. PubMed ID: 29376070
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis.
    Li L; Bensing S; Falhammar H
    Endocrine; 2021 Oct; 74(1):29-37. PubMed ID: 33846948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MANAGEMENT OF ENDOCRINE DISEASE: Glucocorticoid-induced adrenal insufficiency: replace while we wait for evidence?
    Laugesen K; Broersen LHA; Hansen SB; Dekkers OM; Sørensen HT; Jorgensen JOL
    Eur J Endocrinol; 2021 Apr; 184(4):R111-R122. PubMed ID: 33449912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.
    Ceccato F; Barbot M; Lizzul L; Selmin E; Saller A; Albiger N; Betterle C; Boscaro M; Scaroni C
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):201-208. PubMed ID: 28973827
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased Hair Cortisol Concentrations and BMI in Patients With Pituitary-Adrenal Disease on Hydrocortisone Replacement.
    Staufenbiel SM; Andela CD; Manenschijn L; Pereira AM; van Rossum EF; Biermasz NR
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2456-62. PubMed ID: 25816049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current and future treatment options for adrenal insufficiency.
    Arshad MF; Debono M
    Curr Opin Endocrinol Diabetes Obes; 2021 Jun; 28(3):303-311. PubMed ID: 33782339
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2015 Aug; (8):CD008727. PubMed ID: 26282194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is peri-operative steroid replacement therapy necessary for the pituitary adenomas treated with surgery? A systematic review and meta analysis.
    Tohti M; Li J; Zhou Y; Hu Y; Yu Z; Ma C
    PLoS One; 2015; 10(3):e0119621. PubMed ID: 25775019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impaired attention in patients with adrenal insufficiency - Impact of unphysiological therapy.
    Blacha AK; Rahvar AH; Flitsch J; van de Loo I; Kropp P; Harbeck B
    Steroids; 2021 Mar; 167():108788. PubMed ID: 33412217
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
    Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
    Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual-release hydrocortisone and its benefits on cognitive function and quality of sleep.
    Krekeler C; Kropp P; Blacha AK; Rahvar AH; Harbeck B
    Endocrine; 2021 Apr; 72(1):223-233. PubMed ID: 33625720
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
    Harbeck B; Kropp P; Mönig H
    Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency.
    Benson S; Neumann P; Unger N; Schedlowski M; Mann K; Elsenbruch S; Petersenn S
    Eur J Endocrinol; 2012 Nov; 167(5):679-85. PubMed ID: 22930487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapies for adrenal insufficiency.
    Oki K; Yamane K
    Expert Opin Pharmacother; 2007 Jun; 8(9):1283-91. PubMed ID: 17563263
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of diabetes mellitus induced by steroid overtreatment in adrenal insufficiency.
    Guarnotta V; Tomasello L; Giordano C
    Sci Rep; 2022 Jan; 12(1):885. PubMed ID: 35042934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Poor quality of life and sleep in patients with adrenal insufficiency-another cause of increased mortality?
    Blacha AK; Kropp P; Rahvar AH; Flitsch J; van de Loo I; Harbeck B
    Ir J Med Sci; 2022 Aug; 191(4):1653-1658. PubMed ID: 34389925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Gordijn MS; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2012 May; (5):CD008727. PubMed ID: 22592733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.